Statins in tumor suppression
- 3 January 2008
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 260 (1-2) , 11-19
- https://doi.org/10.1016/j.canlet.2007.11.036
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- HMG-CoA reductase inhibitors and the kidneyKidney International, 2007
- Drug Insight: statins for nonischemic heart failure—evidence and potential mechanismsNature Clinical Practice Cardiovascular Medicine, 2007
- Statin Use and Breast Cancer Risk in a Large Population-Based SettingCancer Epidemiology, Biomarkers & Prevention, 2007
- Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activationBlood, 2007
- Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 studyBlood, 2006
- Statins and cancer preventionNature Reviews Cancer, 2005
- Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic MechanismsNature Reviews Drug Discovery, 2005
- A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervixEuropean Journal Of Cancer, 2005
- Therapy Insight: potential of statins for cancer chemoprevention and therapyNature Clinical Practice Oncology, 2005
- Regulation of the mevalonate pathwayNature, 1990